PARTIAL AND FULL DOPAMINE D1-RECEPTOR AGONISTS IN MICE AND RATS - RELATION BETWEEN BEHAVIORAL-EFFECTS AND STIMULATION OF ADENYLATE-CYCLASE ACTIVITY INVITRO

被引:138
作者
ARNT, J
HYTTEL, J
SANCHEZ, C
机构
[1] Pharmacological Research, H. Lundbeck A/S, DK-2500 Copenhagen-Valby
关键词
DOPAMINE D1-RECEPTORS; DOPAMINE D2-RECEPTORS; ADENYLATE CYCLASE; CIRCLING BEHAVIOR; STEREOTYPED BEHAVIOR; LOCOMOTOR ACTIVITY;
D O I
10.1016/0014-2999(92)90690-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dopamine (DA) D1 agonists, SK&F 83959, SK&F 75670, SK&F 38993, SK&F 81297 and SK&F 80723, had variable abilities to stimulate adenylate cyclase activity in rat striatal homogenates. Their efficacies, in relation to the effect of 100-mu-M DA were 0, 33, 69, 68 and 81%, respectively. In rats, all compounds induced (1) contralateral circling behaviour after unilateral 6-hydroxy-DA lesions, (2) ipsilateral circling behaviour after midbrain hemitransection after cotreatment with the D2 agonist quinpirole and (3) oral stereotypies after their combination with quinpirole. Maximum effects and rank order of potencies were similar in the three test models. In mice SK&F 83959, SK&F 75670 and SK&F 38393 inhibited methylphenidate-induced gnawing behaviour and induced no or only weak hypermotility. SK&F 81297 induced marked hypermotility which was partially inhibited by SK&F 83959 and SK&F 75670 and was completely blocked by the D1 antagonist, SCH 23390. It is concluded that no relation could be demonstrated between the efficacy to stimulate adenylate cyclase and to induce circling behaviours and stereotypies in rats. In contrast, a relation between biochemical and behavioural efficacies was found in the mouse models. The results suggest that different subtypes of D1 receptors mediate the behavioural effects reported in this study.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 30 条
[21]   THE INDUCTION OF GROOMING AND VACUOUS CHEWING BY A SERIES OF SELECTIVE D-1 DOPAMINE RECEPTOR AGONISTS - 2 DIRECTIONS OF D-1-D-2 INTERACTION [J].
MURRAY, AM ;
WADDINGTON, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (03) :377-384
[22]   AMPHETAMINE DISCRIMINATION - EFFECTS OF DOPAMINE RECEPTOR AGONISTS [J].
NIELSEN, EB ;
RANDRUP, K ;
ANDERSEN, PH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (02) :253-262
[23]   AGONIST AND ANTAGONIST PROPERTIES OF BENZAZEPINE AND THIENOPYRIDINE DERIVATIVES AT THE D1 DOPAMINE RECEPTOR [J].
OBOYLE, KM ;
GAITANOPOULOS, DE ;
BRENNER, M ;
WADDINGTON, JL .
NEUROPHARMACOLOGY, 1989, 28 (04) :401-405
[24]  
PEDERSEN V, 1972, ACTA PHARMACOL TOX, V31, P488
[25]  
ROGERS D C, 1990, Society for Neuroscience Abstracts, V16, P1054
[27]   CENTRAL EFFECTS OF A NOVEL DOPAMINE AGONIST [J].
SETLER, PE ;
SARAU, HM ;
ZIRKLE, CL ;
SAUNDERS, HL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (04) :419-430
[28]   INTERESTING TIMES FOR DOPAMINE-RECEPTORS [J].
STRANGE, PG .
TRENDS IN NEUROSCIENCES, 1991, 14 (02) :43-45
[29]   DRUGS ACTING ON BRAIN DOPAMINE-RECEPTORS - A CONCEPTUAL RE-EVALUATION 5 YEARS AFTER THE 1ST SELECTIVE D-1 ANTAGONIST [J].
WADDINGTON, JL ;
OBOYLE, KM .
PHARMACOLOGY & THERAPEUTICS, 1989, 43 (01) :1-52
[30]  
WEINSTOCK J, 1985, Drugs of the Future, V10, P645